Independent Advisor Alliance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.2M Sell
39,390
-4,401
-10% -$4.46M 0.39% 53
2025
Q4
$47.1M Sell
43,791
-181
-0.4% -$173K 1.14% 15
2025
Q3
$33.6M Buy
43,972
+812
+2% +$604K 0.87% 18
2025
Q2
$33.6M Sell
43,160
-987
-2% -$767K 0.97% 16
2025
Q1
$36.5M Buy
44,147
+179
+0.4% +$149K 1.2% 13
2024
Q4
$33.9M Buy
43,968
+4,385
+11% +$3.63M 0.45% 43
2024
Q3
$35.1M Sell
39,583
-335
-0.8% -$301K 1.28% 15
2024
Q2
$36.1M Buy
39,918
+7,114
+22% +$5.69M 1.24% 13
2024
Q1
$25.5M Buy
32,804
+535
+2% +$381K 0.92% 21
2023
Q4
$18.8M Buy
32,269
+544
+2% +$318K 0.68% 31
2023
Q3
$17M Buy
31,725
+1,597
+5% +$823K 0.77% 29
2023
Q2
$14.1M Buy
30,128
+1,752
+6% +$735K 0.62% 33
2023
Q1
$9.75M Sell
28,376
-679
-2% -$229K 0.47% 45
2022
Q4
$500K Buy
29,055
+125
+0.4% +$44.3K 0.17% 77
2022
Q3
$9.36M Sell
28,930
-7,333
-20% -$2.32M 0.55% 44
2022
Q2
$11.8M Sell
36,263
-283
-0.8% -$84.9K 0.66% 37
2022
Q1
$10.5M Buy
36,546
+3,564
+11% +$917K 0.5% 51
2021
Q4
$9.11M Buy
32,982
+821
+3% +$208K 0.45% 56
2021
Q3
$7.43M Buy
32,161
+447
+1% +$110K 0.41% 67
2021
Q2
$7.28M Sell
31,714
-3,020
-9% -$607K 0.4% 68
2021
Q1
$6.49M Buy
34,734
+5,175
+18% +$1.01M 0.38% 69
2020
Q4
$4.99M Buy
29,559
+47
+0.2% +$7.02K 0.34% 75
2020
Q3
$4.37M Sell
29,512
-2,370
-7% -$367K 0.33% 81
2020
Q2
$5.21M Sell
31,882
-3,445
-10% -$529K 0.56% 39
2020
Q1
$4.9M Buy
35,327
+6,931
+24% +$952K 0.71% 29
2019
Q4
$3.73M Sell
28,396
-468
-2% -$54.2K 0.16% 138
2019
Q3
$3.23M Buy
28,864
+67
+0.2% +$7.46K 0.39% 55
2019
Q2
$3.19M Sell
28,797
-253
-0.9% -$29.8K 0.46% 45
2019
Q1
$3.77M Buy
29,050
+2,012
+7% +$245K 0.53% 43
2018
Q4
$3.13M Buy
27,038
+579
+2% +$64.7K 0.55% 41
2018
Q3
$2.84M Buy
26,459
+2,437
+10% +$244K 0.51% 43
2018
Q2
$2.04M Sell
24,022
-162
-0.7% -$13.3K 0.43% 58
2018
Q1
$1.83M Buy
24,184
+5
+0% +$403 0.41% 61
2017
Q4
$2.08M Sell
24,179
-47
-0.2% -$4K 0.47% 52
2017
Q3
$2.11M Buy
24,226
+2,336
+11% +$192K 0.58% 44
2017
Q2
$1.8M Buy
21,890
+1,802
+9% +$147K 0.57% 51
2017
Q1
$1.72M Sell
20,088
-58
-0.3% -$4.65K 0.27% 107
2016
Q4
$1.55M Buy
+20,146
New +$1.5M 0.66% 53

Other funds holding LLY

Independent Advisor Alliance's LLY Position: Q1 2026 in Review

Independent Advisor Alliance reduced its Eli Lilly (LLY) stake by 10% in Q1 2026, selling an estimated $4.46M and leaving 39,390 shares worth $36.2M. The position accounts for 0.39% of the portfolio, ranked #53.

Independent Advisor Alliance first reported a position in LLY in Q4 2016 and has held it in 38 quarters since. The position peaked at $47.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Independent Advisor Alliance held 39,390 shares of Eli Lilly worth $36.2M as of Q1 2026.
  • Independent Advisor Alliance sold 4,401 Eli Lilly shares in Q1 2026, an estimated $4.46M.
  • Eli Lilly made up 0.39% of Independent Advisor Alliance's portfolio in Q1 2026, its #53 holding.
  • Independent Advisor Alliance first reported a position in Eli Lilly in Q4 2016 and has held it in 38 quarters since.
  • Independent Advisor Alliance's Eli Lilly position peaked at $47.1M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Independent Advisor Alliance's 13F filing for Q1 2026, filed 12 May 2026.